Director/PDMR Shareholding

Dechra Pharmaceuticals PLC
27 February 2008


27 February 2008

                           Dechra Pharmaceuticals PLC
                                (the 'Company')


The Company announces that Giles Coley, a PDMR, has today exercised the
following unapproved options:


40,000 unapproved options at £1.20 per share;
5,000 unapproved options at £0.585 per share; and
10,000 unapproved options at £1.535 per share.

Mr Coley has then immediately sold 33,000 ordinary shares at £3.95 per share and
he now holds a total interest in 74,474 ordinary shares of the Company.



                      This information is provided by RNS
            The company news service from the London Stock Exchange